MagForce
Health Care, Medical Device, Nanotechnology
Founded in 1/1/97
Berlin, Berlin, Germany
For Profit
About MagForce
MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. The company offers NanoTherm therapy that treats solid tumors through the intratumoral generation of heat by activating superparamagnetic nanoparticles. It also provides NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nanopracticles that is activated in an alternating magnetic field; NanoPlan, a treatment planning software; and NanoActivator, a magnetic field applicator for therapy. The company was founded in 1997 and is headquartered in Berlin, Germany.
Company Metrics
- Employees: 11-50
- Monthly Visits: 3625
- Tech Stack: 11 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 24164015 USD
- Last Funding: 3500000 USD (Post-IPO Debt)
- Funding Status: IPO
Technology Stack
MagForce actively uses 11 products in their tech stack.
Market Presence
Industries: Health Care, Medical Device, Nanotechnology
Headquarters: Berlin, Berlin, Germany